{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T19:46:58Z","timestamp":1785527218854,"version":"3.56.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"vor","delay-in-days":9,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["KL2-TR002346"],"award-info":[{"award-number":["KL2-TR002346"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Med. Toxicol."],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Dexmedetomidine has been used to treat toxicologic conditions, but high-quality data on its use for this indication in the emergency department setting are lacking. We sought to characterize the use of dexmedetomidine in this context.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a dual-center retrospective cohort study of patients treated with dexmedetomidine in two academic emergency departments. We included patients who received dexmedetomidine in the emergency department and had a toxicologic condition, as adjudicated by a medical toxicologist on chart review. We abstracted data from the electronic medical record. We conducted multilevel logistic regression to explore factors associated with intubation after the initiation of dexmedetomidine.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      We screened 1,081 patients and included 320. The most common toxicologic conditions were ethanol withdrawal (20%) and acute poisoning by sympathomimetics (19.7%). Culprit xenobiotics were primarily ethanol and substances of misuse. Median nadir heart rate and mean arterial pressure after dexmedetomidine initiation were normal, and there was no substantial change in nadir hemodynamic parameters after dexmedetomidine administration, although there was an increase in vasopressor administration (6.6% to 11.9%). Among patients who were not intubated when dexmedetomidine was initiated (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009200), the frequency of intubation was 21.5% (95% CI 16\u201328). On multilevel logistic regression, antipsychotic administration was associated with increased odds of intubation (adjusted odds ratio 2.52, 95% CI 1.15\u20135.51).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Dexmedetomidine was primarily used to treat emergency department patients with intoxication or withdrawal from ethanol and substances of misuse. The frequency of intubation in spontaneously breathing patients after the initiation of dexmedetomidine was 21.5%. Further prospective research is needed to evaluate dexmedetomidine in the treatment of toxicologic conditions.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s13181-026-01145-5","type":"journal-article","created":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T13:35:54Z","timestamp":1783690554000},"page":"364-374","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Dexmedetomidine in The Treatment of Toxicologic Conditions in The Emergency Department: A Dual-Center Retrospective Observational Cohort Study"],"prefix":"10.1007","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0875-423X","authenticated-orcid":false,"given":"Kevin","family":"Baumgartner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amar","family":"Chakraborty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David B.","family":"Liss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miya","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taylor","family":"Kaser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Ancona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julianne C.","family":"Yeary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha C.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon B.","family":"Cole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,10]]},"reference":[{"key":"1145_CR1","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1007\/s40262-017-0507-7","volume":"56","author":"MAS Weerink","year":"2017","unstructured":"Weerink MAS, Struys MMRF, Hannivoort LN, Barends CRM, Absalom AR, Colin P. Clinical pharmacokinetics and pharmacodynamics of dexmedetomidine. Clin Pharmacokinet. 2017;56:893\u2013913. https:\/\/doi.org\/10.1007\/s40262-017-0507-7.","journal-title":"Clin Pharmacokinet"},{"key":"1145_CR2","doi-asserted-by":"publisher","first-page":"e825","DOI":"10.1097\/CCM.0000000000003299","volume":"46","author":"JW Devlin","year":"2018","unstructured":"Devlin JW, Skrobik Y, G\u00e9linas C, Needham DM, Slooter AJC, Pandharipande PP, et al. Clinical practice guidelines for the prevention and management of pain, agitation\/sedation, delirium, immobility, and sleep disruption in adult patients in the ICU. Crit Care Med. 2018;46:e825. https:\/\/doi.org\/10.1097\/CCM.0000000000003299.","journal-title":"Crit Care Med"},{"key":"1145_CR3","doi-asserted-by":"publisher","first-page":"2274","DOI":"10.1016\/j.chest.2020.12.052","volume":"159","author":"K Lewis","year":"2021","unstructured":"Lewis K, Piticaru J, Chaudhuri D, Basmaji J, Fan E, M\u00f8ller MH, et al. Safety and efficacy of dexmedetomidine in acutely ill adults requiring noninvasive ventilation: a systematic review and meta-analysis of randomized trials. Chest. 2021;159:2274\u201388. https:\/\/doi.org\/10.1016\/j.chest.2020.12.052.","journal-title":"Chest"},{"key":"1145_CR4","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.2165\/11207190-000000000-00000","volume":"71","author":"SM Hoy","year":"2011","unstructured":"Hoy SM, Keating GM. Dexmedetomidine Drugs. 2011;71:1481\u2013501. https:\/\/doi.org\/10.2165\/11207190-000000000-00000.","journal-title":"Dexmedetomidine Drugs"},{"key":"1145_CR5","doi-asserted-by":"publisher","first-page":"323","DOI":"10.4097\/kja.19259","volume":"72","author":"S Lee","year":"2019","unstructured":"Lee S. Dexmedetomidine: present and future directions. Korean J Anesthesiol. 2019;72:323\u201330. https:\/\/doi.org\/10.4097\/kja.19259.","journal-title":"Korean J Anesthesiol"},{"key":"1145_CR6","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1001\/jama.2012.304","volume":"307","author":"SM Jakob","year":"2012","unstructured":"Jakob SM, Ruokonen E, Grounds RM, Sarapohja T, Garratt C, Pocock SJ, et al. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA. 2012;307:1151\u201360. https:\/\/doi.org\/10.1001\/jama.2012.304.","journal-title":"JAMA"},{"key":"1145_CR7","doi-asserted-by":"publisher","first-page":"454","DOI":"10.3109\/15563650.2014.898770","volume":"52","author":"JA Lowry","year":"2014","unstructured":"Lowry JA, Brown JT. Significance of the imidazoline receptors in toxicology. Clin Toxicol (Phila). 2014;52:454\u201369. https:\/\/doi.org\/10.3109\/15563650.2014.898770.","journal-title":"Clin Toxicol (Phila)"},{"key":"1145_CR8","doi-asserted-by":"publisher","unstructured":"Baumgartner K, Doering And M, Mullins ME, Toxicology investigators consortium. Dexmedetomidine in the treatment of toxicologic conditions: a systematic review and review of the toxicology investigators consortium database. Clin Toxicol (Phila). 2022;60:1356\u201375. https:\/\/doi.org\/10.1080\/15563650.2022.2138761","DOI":"10.1080\/15563650.2022.2138761"},{"key":"1145_CR9","doi-asserted-by":"publisher","first-page":"525","DOI":"10.3109\/15563650.2014.913175","volume":"52","author":"PL Mohorn","year":"2014","unstructured":"Mohorn PL, Vakkalanka JP, Rushton W, Hardison L, Woloszyn A, Holstege C, et al. Evaluation of dexmedetomidine therapy for sedation in patients with toxicological events at an academic medical center. Clin Toxicol (Phila). 2014;52:525\u201330. https:\/\/doi.org\/10.3109\/15563650.2014.913175.","journal-title":"Clin Toxicol (Phila)"},{"key":"1145_CR10","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1093\/ajhp\/zxac378","volume":"80","author":"E Kershner","year":"2023","unstructured":"Kershner E, Tobarran N, Chambers A, Jenkins Z, Wills BK, Cumpston KL. Clinical characteristics and outcomes using dexmedetomidine in nonintubated patients: A poison center observational study. Am J Health Syst Pharm. 2023;80:526\u201331. https:\/\/doi.org\/10.1093\/ajhp\/zxac378.","journal-title":"Am J Health Syst Pharm"},{"key":"1145_CR11","first-page":"26","volume":"14","author":"J Rizer","year":"2018","unstructured":"Rizer J, Oldham R, Rege S, Wiley S, Charlton N. Dexmedetomidine use in the critically ill poisoned patient [Abstract 067]. J Med Toxicol. 2018;14:26.","journal-title":"J Med Toxicol"},{"key":"1145_CR12","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1111\/acem.14636","volume":"30","author":"K Baumgartner","year":"2023","unstructured":"Baumgartner K, Groff V, Yaeger LH, Fuller BM. The use of dexmedetomidine in the emergency department: a systematic review. Acad Emerg Med. 2023;30:196\u2013208. https:\/\/doi.org\/10.1111\/acem.14636.","journal-title":"Acad Emerg Med"},{"key":"1145_CR13","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","volume":"370","author":"E von Elm","year":"2007","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370:1453\u20137. https:\/\/doi.org\/10.1016\/S0140-6736(07)61602-X.","journal-title":"Lancet"},{"key":"1145_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2019.103208","volume":"95","author":"PA Harris","year":"2019","unstructured":"Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O\u2019Neal L, et al. The REDCap consortium: building an international community of software platform partners. J Biomed Inform. 2019;95:103208. https:\/\/doi.org\/10.1016\/j.jbi.2019.103208.","journal-title":"J Biomed Inform"},{"key":"1145_CR15","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42:377\u201381. https:\/\/doi.org\/10.1016\/j.jbi.2008.08.010.","journal-title":"J Biomed Inform"},{"key":"1145_CR16","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s13181-025-01099-0","volume":"22","author":"K Aldy","year":"2024","unstructured":"Aldy K, Li S, Costantini M, Falise A, Culbreth R, Wax PM, et al. The Toxicology Investigators Consortium 2024 annual report. J Med Toxicol. 2024;22:2\u201328. https:\/\/doi.org\/10.1007\/s13181-025-01099-0.","journal-title":"J Med Toxicol"},{"key":"1145_CR17","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1097\/TME.0000000000000184","volume":"40","author":"MK Pop","year":"2018","unstructured":"Pop MK, Dervay KR, Dansby M, Jones C. Evaluation of Richmond Agitation Sedation Scale (RASS) in mechanically ventilated in the emergency department. Adv Emerg Nurs J. 2018;40:131\u20137. https:\/\/doi.org\/10.1097\/TME.0000000000000184.","journal-title":"Adv Emerg Nurs J"},{"key":"1145_CR18","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/s0140-6736(74)91639-0","volume":"2","author":"G Teasdale","year":"1974","unstructured":"Teasdale G, Jennett B. <article-title update=\"added\">Assessment of coma and impaired consciousness. Lancet. 1974;2:81\u20134. https:\/\/doi.org\/10.1016\/s0140-6736(74)91639-0.","journal-title":"Lancet"},{"key":"1145_CR19","doi-asserted-by":"publisher","DOI":"10.1097\/CCE.0000000000001066","volume":"6","author":"DC To","year":"2024","unstructured":"To DC, Steel TL, Carey KA, Joyce CJ, Salisbury-Afshar EM, Edelson DP, et al. Alcohol withdrawal severity measures for identifying patients requiring high-intensity care. Crit Care Explor. 2024;6:e1066. https:\/\/doi.org\/10.1097\/CCE.0000000000001066.","journal-title":"Crit Care Explor"},{"key":"1145_CR20","doi-asserted-by":"publisher","unstructured":"Kotani Y, Di Gioia A, Landoni G, Belletti A, Khanna AK. An updated \u201cnorepinephrine equivalent\u201d score in intensive care as a marker of shock severity. Crit Care. London, England; 2023;27:29. https:\/\/doi.org\/10.1186\/s13054-023-04322-y","DOI":"10.1186\/s13054-023-04322-y"},{"key":"1145_CR21","doi-asserted-by":"publisher","unstructured":"Fishburn SJ, Mullins ME. A simple approximation of the QT nomogram. Clin Toxicol (Phila). Philadelphia, Pa.; 2021;59:177\u20138. https:\/\/doi.org\/10.1080\/15563650.2020.1768267","DOI":"10.1080\/15563650.2020.1768267"},{"key":"1145_CR22","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1093\/qjmed\/hcm072","volume":"100","author":"A Chan","year":"2007","unstructured":"Chan A, Isbister GK, Kirkpatrick CMJ, Dufful SB. Drug-induced QT prolongation and torsades de pointes: evaluation of a QT nomogram. QJM. 2007;100:609\u201315. https:\/\/doi.org\/10.1093\/qjmed\/hcm072.","journal-title":"QJM"},{"key":"1145_CR23","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.5811\/westjem.2021.4.50917","volume":"22","author":"J Sinnott","year":"2021","unstructured":"Sinnott J, Holthaus CV, Ablordeppey E, Wessman BT, Roberts BW, Fuller BM. The use of dexmedetomidine in the emergency department: a cohort study. West J Emerg Med. 2021;22:1202\u20139. https:\/\/doi.org\/10.5811\/westjem.2021.4.50917.","journal-title":"West J Emerg Med"},{"key":"1145_CR24","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1111\/acem.14842","volume":"31","author":"K Baumgartner","year":"2024","unstructured":"Baumgartner K, Joseph M, Lothet E, Fuller BM. Dexmedetomidine in the emergency department: a prospective observational cohort study. Acad Emerg Med. 2024;31:263\u201372. https:\/\/doi.org\/10.1111\/acem.14842.","journal-title":"Acad Emerg Med"},{"key":"1145_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/ph17091125","volume":"17","author":"M Fiore","year":"2024","unstructured":"Fiore M, Alfieri A, Torretta G, Passavanti MB, Sansone P, Pota V, et al. Dexmedetomidine as adjunctive therapy for the treatment of alcohol withdrawal syndrome: a systematic review and meta-analysis. Pharmaceuticals (Basel). 2024;17:1125. https:\/\/doi.org\/10.3390\/ph17091125.","journal-title":"Pharmaceuticals (Basel)"},{"key":"1145_CR26","doi-asserted-by":"publisher","DOI":"10.1093\/alcalc\/agaf047","volume":"60","author":"JD DelBianco","year":"2025","unstructured":"DelBianco JD, Galeano KJ, Beauchamp GA, Surmaitis RM, Shara SE, Sutter A, et al. Trends in alcohol withdrawal management by medical toxicologists in the acute care setting: an analysis of the Toxicology Investigators Consortium (ToxIC) Core Registry, 2016-2022. Alcohol Alcohol. 2025;60:agaf047. https:\/\/doi.org\/10.1093\/alcalc\/agaf047.","journal-title":"Alcohol Alcohol"},{"key":"1145_CR27","doi-asserted-by":"publisher","first-page":"601","DOI":"10.14740\/jocmr6361","volume":"17","author":"A Ashok","year":"2025","unstructured":"Ashok A, Sharma R, Ahmed S, Calvo EM, Warnick J, Zalavadia D, et al. Assessment of the treatment for alcohol withdrawal syndrome with and without Dexmedetomidine: a retrospective cohort study. J Clin Med Res. 2025;17:601\u20137. https:\/\/doi.org\/10.14740\/jocmr6361.","journal-title":"J Clin Med Res"},{"key":"1145_CR28","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.ajem.2020.12.079","volume":"42","author":"JL Stang","year":"2021","unstructured":"Stang JL, DeVries PA, Klein LR, Cole JB, Martel M, Reing ML, et al. Medical needs of emergency department patients presenting with acute alcohol and drug intoxication. Am J Emerg Med. 2021;42:38\u201342. https:\/\/doi.org\/10.1016\/j.ajem.2020.12.079.","journal-title":"Am J Emerg Med"},{"key":"1145_CR29","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.annemergmed.2023.08.009","volume":"83","author":"AE Robinson","year":"2024","unstructured":"Robinson AE, Driver BE, Cole JB, Miner JR, Dreyfuss AP, Strom AW, et al. Factors associated with physical restraint in an urban emergency department. Ann Emerg Med. 2024;83:91\u20139. https:\/\/doi.org\/10.1016\/j.annemergmed.2023.08.009.","journal-title":"Ann Emerg Med"},{"key":"1145_CR30","doi-asserted-by":"publisher","first-page":"e2551683","DOI":"10.1001\/jamanetworkopen.2025.51683","volume":"8","author":"JB Cole","year":"2025","unstructured":"Cole JB, Hurrah KM, Taghizadeh LA, Laudenbach AP, Olives TD, Miner JR, et al. Oral medications for treating agitation in a safety net emergency department. JAMA Netw Open. 2025;8:e2551683. https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.51683.","journal-title":"JAMA Netw Open"},{"key":"1145_CR31","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1080\/15563650.2025.2591356","volume":"64","author":"KZ Isoardi","year":"2026","unstructured":"Isoardi KZ, Cole JB, Hoffman RS, Isbister GK. What is the best approach for parenteral sedation to manage severe acute behavioral disturbance in the emergency department? Clin Toxicol (Phila). 2026;64:79\u201385. https:\/\/doi.org\/10.1080\/15563650.2025.2591356.","journal-title":"Clin Toxicol (Phila)"},{"key":"1145_CR32","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1904710","author":"Y Shehabi","year":"2019","unstructured":"Shehabi Y, Howe BD, Bellomo R, Arabi YM, Bailey M, Bass FE, et al. Early sedation with Dexmedetomidine in critically ill patients. N Engl J Med. 2019. https:\/\/doi.org\/10.1056\/NEJMoa1904710.","journal-title":"N Engl J Med"},{"key":"1145_CR33","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2025.7200","author":"TS Walsh","year":"2025","unstructured":"Walsh TS, Parker RA, Aitken LM, McKenzie CA, Emerson L, Boyd J, et al. Dexmedetomidine- or Clonidine-based sedation compared with Propofol in critically ill patients: the A2B randomized clinical trial. JAMA. 2025. https:\/\/doi.org\/10.1001\/jama.2025.7200.","journal-title":"JAMA"},{"key":"1145_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-023-07764-5","volume":"24","author":"BM Fuller","year":"2023","unstructured":"Fuller BM, Driver BE, Roberts MB, Schorr CA, Thompson K, Faine B, et al. Awareness with paralysis and symptoms of post-traumatic stress disorder among mechanically ventilated emergency department survivors (ED-AWARENESS-2 Trial): study protocol for a pragmatic, multicenter, stepped wedge cluster randomized trial. Trials. 2023;24:753. https:\/\/doi.org\/10.1186\/s13063-023-07764-5.","journal-title":"Trials"},{"key":"1145_CR35","doi-asserted-by":"publisher","first-page":"2446","DOI":"10.1001\/jama.2022.21383","volume":"328","author":"MA Hern\u00e1n","year":"2022","unstructured":"Hern\u00e1n MA, Wang W, Leaf DE. Target trial emulation: a framework for causal inference from observational data. JAMA. 2022;328:2446\u20137. https:\/\/doi.org\/10.1001\/jama.2022.21383.","journal-title":"JAMA"},{"key":"1145_CR36","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1097\/CCM.0000000000005558","volume":"50","author":"BM Fuller","year":"2022","unstructured":"Fuller BM, Roberts BW, Mohr NM, Faine B, Drewry AM, Wessman BT, et al. The feasibility of implementing targeted SEDation in mechanically ventilated emergency department patients: the ED-SED pilot trial. Crit Care Med. 2022;50:1224\u201335. https:\/\/doi.org\/10.1097\/CCM.0000000000005558.","journal-title":"Crit Care Med"}],"container-title":["Journal of Medical Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13181-026-01145-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13181-026-01145-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13181-026-01145-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T18:10:11Z","timestamp":1785521411000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13181-026-01145-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["1145"],"URL":"https:\/\/doi.org\/10.1007\/s13181-026-01145-5","relation":{},"ISSN":["1556-9039","1937-6995"],"issn-type":[{"value":"1556-9039","type":"print"},{"value":"1937-6995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"17 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors report no conflicts of interest.","order":1,"name":"Ethics","label":"Conflicts of Interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}